1 |
Cyclophosphamide
💬 | [1] Cyclophosphamide Cyclophosphamide | [5] Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide monohydrate | - | - | [46] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 220, 221, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
2 |
Cyclophosphamide
💬 | [1] Cyclophosphamide Cyclophosphamide | [5] Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide monohydrate | - | - | [46] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 220, 221, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
3 |
Methylprednisolone
💬 | [1] Methylprednisolone Methylprednisolone | [3] Methylprednisolon Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
4 |
Methylprednisolone acetate
💬 | [1] Methylprednisolone Methylprednisolone | [3] Methylprednisolon Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
5 |
Pentoxifylline
💬 | [1] Pentoxifylline Pentoxifylline | [1] Pentoxifylline Pentoxifylline | - | - | [11] 26 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
|
6 |
Pioglitazone
💬 | [1] Pioglitazone Pioglitazone | [1] Pioglitazone Pioglitazone | [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [16] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
|
7 |
Pioglitazone hydrochloride
💬 | [1] Pioglitazone Pioglitazone | [1] Pioglitazone Pioglitazone | [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [16] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 220, 229, 265, 298, 299 💬
|
8 |
Rituximab
💬 | [1] Rituximab Rituximab | [1] Rituximab Rituximab | [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [52] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|